Merck and Roche extend distribution ties
December 5, 2016Manufacturing and Production Merck, Roche, distribution
Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …
Takeda to invest €40m in Dublin operations expansion
December 5, 2016Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda
Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …
Mission Therapeutics announces new non-executive chairman
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment
Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
Scientists create ‘map of drugs’ to aid further development
December 5, 2016Manufacturing and Production, Medical Communications
Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …
Veeva announces Veeva CRM Engage Meeting at European Commercial Summit
December 5, 2016Medical Communications Big Data, CRM, veeva
Veeva, a cloud software company, concluded its annual European Commercial Summit last week, held this year in Madrid. The conference …
FDA approves another indication for Lilly/Boehringer diabetes treatment
December 5, 2016Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance
Jardiance (empagliflozin), an oral SGLT02 inhibitor developed by Eli Lilly and distributed by Boehringer Ingelheim, has been approved by the …
Technology and patient adherence: Putting control of medication directly in patients’ hands
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing apps, patient adherence, technology
Ben Hargreaves looks at how apps and medical devices could reduce these figures by providing patients new ways of keeping …
ReNeuron’s stem cell therapy improves motor function in stroke study
December 5, 2016Research and Development ReNeuron, stem cell, stem cell therapy, stroke
ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …
Ablynx secures first €1m milestone payment from Novo Nordisk
December 5, 2016Sales and Marketing Ablynx, Novo Nordisk, nanobody
Ablynx has secured €1 million from Novo Nordisk as it hits its first discovery milestone for its multi-specific nanobody construct, …
New molecular-binding technique promises accelerated drug development
December 5, 2016Research and Development, Sales and Marketing Alzheimer's, Cancer, Indiana University-Purdue University Indianapolis
Researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) have claimed to have designed a new molecular …
Novartis posts 82% remission rate in CAR T paediatric study
December 5, 2016Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric
Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …
Pfizer teams up with IBM Watson Health in immuno-oncology
December 2, 2016Medical Communications Pfizer, Watson, Watson Health, drug discovery, ibm
Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …
Top Ten most popular articles on Pharmafile this week
December 2, 2016Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories
This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …
Looking back at the biggest deal of 2016: Bayer-Monsanto
December 2, 2016Medical Communications Bayer, acquisition, big deal, monsanto, pharma deal 2016
The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September …
J&J hit by $1bn hip implant lawsuit
December 2, 2016Medical Communications J&J, JJ, lawsuit
Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …
AstraZeneca seals $1 billion deal with Bicycle Therapeutics
December 2, 2016Medical Communications, Sales and Marketing AstraZeneca, Bicycle Therapeutics
Bicycle Therapeutics, Cambridge-based British biotech firm, has announced that it has signed a deal that could potentially be worth over …
NICE approves MSD’s Keytruda for new cancer indication
December 1, 2016Medical Communications, Sales and Marketing MSD, NICE, keytruda
The National Institute of Health and Care Excellence (NICE) has announced its recommendation of MSD’s immunotherapy drug Keytruda (pembrolizumab) for …
Kite Pharma names new senior VP of Supply Chain
December 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma
Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …
Takeda to build €100 million dengue vaccine manufacturing plant
December 1, 2016Manufacturing and Production, Medical Communications Takeda, dengue, phase 3
Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …
Eisai & Clinigen to bring breast cancer drug to South Africa
December 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer
Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
